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X-linked recessive hypoparathyroidism, due to parathyroid agenesis, has been mapped to a 906-kb region on
Xq27 that contains 3 genes (ATP11C, U7snRNA, and SOX3), and analyses have not revealed mutations. We
therefore characterized this region by combined analysis of single nucleotide polymorphisms and sequencetagged sites. This identified a 23- to 25-kb deletion, which did not contain genes. However, DNA fiber–FISH
and pulsed-field gel electrophoresis revealed an approximately 340-kb insertion that replaced the deleted
fragment. Use of flow-sorted X chromosome–specific libraries and DNA sequence analyses revealed that the
telomeric and centromeric breakpoints on X were, respectively, approximately 67 kb downstream of SOX3
and within a repetitive sequence. Use of a monochromosomal somatic cell hybrid panel and metaphase-FISH
mapping demonstrated that the insertion originated from 2p25 and contained a segment of the SNTG2 gene
that lacked an open reading frame. However, the deletion-insertion [del(X)(q27.1) inv ins (X;2)(q27.1;p25.3)],
which represents a novel abnormality causing hypoparathyroidism, could result in a position effect on SOX3
expression. Indeed, SOX3 expression was demonstrated, by in situ hybridization, in the developing parathyroid tissue of mouse embryos between 10.5 and 15.5 days post coitum. Thus, our results indicate a likely new
role for SOX3 in the embryonic development of the parathyroid glands.
*OUSPEVDUJPO
Hypoparathyroidism (HPT) is an endocrine disorder in which
hypocalcemia and hyperphosphatemia are the results of a deficiency of parathyroid hormone (PTH) (1). The causes of HPT include
trauma to the parathyroids during neck surgery, autoimmune
polyendocrinopathy syndrome type 1, or the complex congential
abnormalities of the DiGeorge, Kenny-Caffey, and hypoparathyroidism, deafness, and renal dysplasia (HDR) syndromes (1, 2). In
addition, HPT may develop as an isolated endocrinopathy that
may also be inherited as autosomal dominant (Online Mendelian
Inheritance in Man [OMIM] 146200), autosomal recessive (OMIM
146200), or X-linked recessive traits (OMIM 307700) (1, 3–5).
Some of the autosomal forms of isolated HPT are due to mutations of the PTH gene (1, 3), which is located on chromosome
Nonstandard abbreviations used: ATP11C, adenosine triphosphatase 11C; BAC,
bacterial artificial chromosome; BLAST, Basic Local Alignment Search Tool; CASR,
calcium-sensing receptor; dpc, days post coitum; HDR, hypoparathyroidism, deafness, and renal dysplasia; HPT, hypoparathyroidism; ISP, insert-specific primer; LOD,
log10 of odds; OMIM, Online Mendelian Inheritance in Man; PAC, P1-derived artificial chromosome; PFGE, pulsed-field gel electrophoresis; PH, pleckstrin homology;
PTH, parathyroid hormone; RACE, rapid amplification of cDNA ends; SHH, sonic
hedgehog; SNP, single nucleotide polymorphism; SNTG2, syntrophin gamma 2;
SOX3, Sry-box 3; STS, sequence-tagged site; SU, syntrophin unique; XSP, X chromosome–specific primer; YAC, yeast artificial chromosome.
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11p15, or the calcium-sensing receptor gene (CASR), which is located
on chromosome 3q21.3 (1, 6). The gene causing the X-linked recessive form, which seems to involve a developmental gene and has
been mapped to Xq27, remains to be identified (7–9).
X-linked recessive HPT (OMIM 307700) has been reported in 2
related multigeneration kindreds from Missouri, USA (4, 5, 10).
Affected subjects, who are males, suffered, if untreated, from neonatal or infantile onset of hypocalcemic seizures (4, 5). These individuals have deficiency of circulating immunoreactive PTH, and an
autopsy of an affected teenage boy indicated that the HPT was due
to parathyroid agenesis (11). Clinical immunodeficiency, facial dysmorphism, deafness, and renal abnormalities, which are notable features of some complex congential anomalies (e.g., DiGeorge, HDR,
and Kenny-Caffey syndromes) (1, 12), are not present in males with
X-linked recessive HPT (4, 5). Carrier females, who are the mothers
or grandmothers of affected males, give no history of epilepsy and
are normocalcemic (4, 5). Linkage studies have mapped X-linked
recessive HPT to a 906-kb interval (Figure 1) flanked centromerically
by a polymorphism associated with the diffuse B cell lymphoma (DBL)
proto-oncogene and telomerically by DXS984 in Xq27.1 (7–9). Furthermore, DNA sequence analyses of the 3 genes, adenosine triphosphatase 11C (ATP11C), U7snRNA homologue, and Sry-box 3 (SOX3), that are
contained within the 906-kb X-linked recessive HPT critical region
have not revealed any abnormalities (9). These findings together with
the reported absence of hypocalcemia in a boy with hemophilia B and
mental retardation who had a chromosomal deletion that encom-
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passed the entire 906-kb interval containing ATP11C, U7snRNA,
and SOX3 genes (8, 9, 13) suggest that other genomic abnormalities
such as duplications or translocations, which could cause altered
gene function (14–19), may underlie the etiology of X-linked recessive HPT. We therefore undertook a detailed characterization of the
interval containing the X-linked recessive HPT locus.
3FTVMUT
Identification of a deletion-insertion in X-linked recessive HPT. Our initial
characterization of the X-linked recessive HPT interval began with
the identification of single nucleotide polymorphisms (SNPs) for
segregation studies, with a view to reducing the critical region by
identifying recombinants between the disease and SNP loci. The
interval between the DBL-associated SNP, rs5907612, and DXS984
(Figure 1), which is 906 kb in size (9), is contained within a contig formed by 12 bacterial artificial chromosomes (BACs), and a
search using the GenBank database revealed 2 SNPs (rs732125
and rs461191) centromeric to the loci for U7snRNA and SOX3.
The family members of the 2 X-linked recessive HPT kindreds,
P/60 and W/81 (4, 5), were homozygous and hence uninformative
for SNP rs461191. However, a deletion involving SNP rs732125
was detected in the 6 males affected with X-linked recessive HPT,
and use of 5 sequence-tagged sites (STSs) derived from the DNA
sequence of BAC RP11-51C14 revealed that this deletion was less
than or equal to 28 kb in size (Figure 1).
The Journal of Clinical Investigation

The use of long-range SfiI restriction endonuclease mapping utilizing pulsed-field gel electrophoresis (PFGE) studies (20) with a
[32P]-labeled SOX3 probe (Figure 2) and long-range PCR (data not
shown) to confirm this deletion did not reveal the expected loss of
a DNA fragment up to 28 kb in size. Instead, a gain of a large insertion at the site of the deletion was observed (Figure 2). In order to
characterize the boundaries of this deletion-insertion and to determine its DNA sequence, vectorette libraries (20–22) of genomic
DNA digested with BamHI, EcoRI, HindIII, HpaII, and RsaI were
constructed for both a normal male (individual IV.14; Figure 2) and
a male affected with X-linked recessive HPT (individual IV.15). In
addition, X chromosome–specific EcoRI, RsaI, and TaqI vectorette
libraries were constructed using flow-sorted chromosomes from a
male affected with X-linked recessive HPT (individual IV.15; Figure
2). PCR products were generated utilizing X chromosome–specific
and vectorette unit binding primers, and amplicons containing the
breakpoints were identified by use of an oligomer-extension “hot
blot” assay (23). These targeted PCR products were subcloned into
pGEM-T and their DNA sequences determined (24). This revealed
that the telomeric breakpoint had occurred between nucleotides
38,597 and 38,598 of BAC RP11-51C14 (Figure 1). However, the
centromeric breakpoint had occurred within a 2 kb (at) dinucleotide-rich repetitive sequence. This rendered it difficult to establish the exact position of the centromeric breakpoint within this
region, which spanned between nucleotides 13,500 and 15,500 of
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BAC RP11-51C14 (Figure 1). These findings established that the
deletion was between 23 and 25 kb in size and involved Xq27.1. An
approximately 1,750-bp BamHI vectorette PCR product encompassing the telomeric breakpoint, and adjoining insert DNA was
sequenced. A Basic Local Alignment Search Tool (BLAST) analysis,
using the versions available in 2001–2003, of this insert sequence
obtained from the telomeric breakpoint did not identify any
matches in the databases. This sequence was used to design insertspecific primer 1 (ISP1) and ISP2 that would generate insert-specific PCR products (Figure 3). These were used with DNA from
a monochromosomal rodent-human somatic cell hybrid panel
(25), and the insert-specific sequence was shown to originate from
human chromosome 2 (Figure 3). In addition, a third ISP, ISP3,
was used in conjunction with X chromosome–specific primer R
(XSPR) to generate a hybrid PCR product that was specific for the
HPT telomeric boundary (Figure 3). This revealed the hybrid PCR
product, which was 321 bp in size (Figure 3), to be present in all
of the 6 hemizygous males affected with HPT and in all of the 11
carrier females, who were heterozygous and also had the normal
237-bp product. The hybrid PCR product was not present in any
of the 16 unaffected males or 28 unaffected females, all of whom
had the normal PCR product. Thus, there was cosegregation, with
a peak log10 of odds (LOD) score of 8.10 at 0% recombination, of
the deletion-insertion with HPT in the 2 related kindreds.
Characterization of the insertion reveals origin from chromosome 2p25.3.
The ISPs (ISP1 and ISP2) were utilized to generate a 1,181-bp
PCR product (Figure 3) that was radiolabeled and used to screen
chromosome 2–specific P1-derived artificial chromosome (PAC)
(LL02NP04) and Fosmid (LL02NC03) libraries (26) and the
Centre d’Études du Polymorphisme Humain (CEPH) megaYAC
library (27). This yielded 1 positive fosmid clone, AG63A8, and 1
nonchimeric yeast artificial chromosome (YAC) clone, 972C12.
Combined use of the fosmid clone, from chromosome 2, with BAC
RP11-51C14, from Xq27, in dual-color FISH analyses (28) of metaphase spreads, confirmed the presence of the insertion at Xq27.1
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and revealed that it originated from chromosome 2p25 (Figure 4).
Thus, in normal males hybridization with fosmid AG63A8 yielded
signals from chromosome 2pter only; whereas, in males affected
with X-linked recessive HPT and in female carriers, fosmid AG63A8
hybridization signals were observed from chromosome 2pter and
Xqter. Furthermore, the merging of the green signal, from fosmid AG63A8, with the red signal, from BAC RP11-51C14, on the
X chromosome harboring the deletion-insertion to yield a yellow
signal and the use of DNA fibre-FISH analysis (28) revealed that
the 2p25 insertion was adjacent to the BAC RP11-51C14 sequence
(Figure 4). Thus, a contiguous signal was obtained from the 2 X chromosome BACs RP11-359I11 and RP11-51C14 in the normal male,
consistent with their juxtaposed locations (Figures 1 and 4). However, such a contiguous signal was not observed in the male affected with X-linked recessive HPT, whereas use of the chromosome
2p25–derived YAC 972C12 yielded a contiguous signal (Figure 4).
These findings, which indicate the insertion of chromosome 2p25
sequence within that of Xq27.1 sequence, are consistent with the
presence of a deletion-insertion in the male affected with X-linked
recessive HPT. This event is likely to have arisen in the founder,
more than 6 generations ago (4, 5), by nonhomologous recombination that probably involved the (at) dinucleotide-rich repetitive
sequence at the centromeric breakpoint of the deletion on Xq27.1
(Figure 3). The precise nature of any other associated chromosomal
abnormalities, such as deletions of 2p25, in the founder cannot be
determined. However, it is important to note that males affected
with X-linked recessive HPT and carrier females have normal copies of chromosome 2 (Figure 4). Thus, the occurrence of X-linked
recessive HPT in the progeny of the founder is due to inheritance
of the abnormal X chromosome that harbors the deletion-insertion
involving chromosomes Xq27.1 and 2p25.
The extent of the chromosome 2p25 insert was further characterized by first determining the end sequences (20) of YAC 972C12
and then identifying BACs that contained these sequences, with
the aim of assembling a tiled path of such clones (Figure 4). BACs
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BMMUIFNFNCFSTPGGBNJMJFT8  BOE
1  ZJFMEFEB-0%TDPSFPGBU
SFDPNCJOBUJPO

RP11-455F15 and RP13-542C4 contained DNA sequences that
matched the left- and right-arm end sequences of YAC 972C12,
respectively, and the sequences of these BACs were in turn
used to identify 6 other BACs (i.e., RP13-539J13, RP11-97B21,
CTD2029L3, RP11-1268F2, RP13-932E12, and RP11-1294H20)
and 1 fosmid (XXfos-83269E11) to assemble a contig. The size of
the insert sequence was estimated to be less than or equal to 500 kb
by DNA fiber–FISH analysis (28) that utilized the chromosome
Xq27 BACs RP11-359I11 and RP11-51C14 and the chromosome
2p25–derived YAC 972C12 (Figure 4). These results also revealed
that the entire 2p25 insert was contained within the 750-kb sequence
of YAC 972C12. The use of DNA from these clones and ISPs (ISP1
and ISP2; Figure 3) for the telomeric boundary in PCRs established that this breakpoint was on BAC CTD-2029L3, and the use
of metaphase-FISH analysis (28) confirmed this and revealed that
the entire 176-kb sequence of RP11-1268F2 was contained within
the insert and that RP13-542C4 harbored the centromeric boundary (Figure 4). These results also revealed that the chromosome
The Journal of Clinical Investigation

2p25 sequence was inverted upon insertion at Xq27.1 (Figure 5).
DNA sequence analysis of the chromosome 2p25 clones and the
insert revealed that the 2p telomeric breakpoint of the insert was
between nucleotides 94,427 and 94,428 of BAC CTD-2029L3 and
that the centromeric breakpoint was located between nucleotides
40,000 and 75,000 of BAC RP13-542C4, thereby indicating that
the size of the insert was 305–340 kb and from 2p25.3. Thus,
X-linked recessive HPT is caused by a molecular deletion-insertion [del(X)(q27.1) inv ins (X;2)(q27.1;p25.3)] involving a loss of
23–25 kb from Xq27.1 and an inverted insertion of 305–340 kb
from 2p25.3 to Xq27.1. A search for such a deletion-insertion and
other deletions or insertions in 9 unrelated males with idiopathic
HPT using PCR primers for the 2 SNPs (rs732125 and rs461191;
Figure 1), the 5 STSs (a–e; Figure 1), and the telomeric breakpoint
of X-linked recessive HPT (ISP3 and XSPR; Figure 3) did not reveal
any abnormalities, thereby indicating that the deletion-insertion
del(X)(q27.1) inv ins (X;2)(q27.1;p25.3) is likely to be a rare event
that has occurred in the 2 related kindreds from Missouri (8).
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Search for expressed sequences within the deletion-insertion. In order
to elucidate further the genetic consequences of this complex
chromosomal rearrangement associated with X-linked recessive
HPT, we investigated the involved DNA sequences for expressed
genes. The 2p25.3 inserted 305–340 kb sequence contained a
large segment of the syntrophin gamma 2 (SNTG2; NM_018968)
gene, that consists of the 3′ part of intron 1 together with exons
2 to 16 and the 5′ part of intron 16. Thus, this inserted segment of the SNTG2 gene did not contain the normally utilized
start and stop codons, which are in exons 1 and 17, respectively
(29). However, SNTG2 has been reported to have alternative transcripts (29), and our analysis of the DNA sequences indicated
that there may be alternative exons within the 2p25.3 inserted approximately 61 kb of intron 1 and the adjacent Xq27.1
sequence (Figure 5). The usage of these was investigated by utilizing EBV-transformed lymphoblastoid RNA from males affected with X-linked recessive HPT and normal males for RT-PCR
analysis (3). These analyses in both the affected and normal
individuals revealed that 2 upstream exons were spliced to the
invariant exon 2 of SNTG2, but DNA sequence analysis revealed
that the resultant transcripts did not have open reading frames
(data not shown) and that they were therefore not likely to be of
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functional significance. These results were confirmed by analyzing alternative SNTG2 transcripts that were obtained by use of
5′ rapid amplification of cDNA ends (RACE) and human kidney
Marathon-Ready cDNA (BD Biosciences) (30) (data not shown).
The 23- to 25-kb sequence deleted from Xq27.1 deleted 23–25 kb
sequence is not known to contain any genes or ESTs, but nucleic
acid identification X (NIX) analysis indicated the presence of 4
putative exons. Oligonucleotide primers specific for these were
designed and utilized in RT-PCR analysis that used 35 cycles to
facilitate detection of low levels of illegitimate transcripts (3) in
RNA from EBV-transformed lymphoblastoids of a normal male,
as normal human adult or embryonic parathyroid tissue was
not available. The RT-PCR analysis failed to detect transcripts,
thereby indicating that this 23- to 25-kb sequence deleted from
Xq27.1 is likely to be a noncoding region, although it is important to note that illegitimate transcripts of developmental genes
may occasionally not be detected in RNA from EBV-transformed
lymphoblastoids (3, 17).
Sox3 expression in developing parathyroids. The noncoding region
encompassed by the 23- to 25-kb deleted sequence is situated 67
kb downstream of SOX3, and this location suggested the possibility that this region could regulate SOX3 transcription. Indeed,
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mLCBOEJODMVEFTFYPOTmPGUIF4/5(HFOF5IFMPDBUJPOPGUIJTEFMFUJPOJOTFSUJPOJTBQQSPYJNBUFMZLCEPXOTUSFBNPGUIFHFOF
FODPEJOH409 XIJDICFMPOHTUPBGBNJMZPGUSBOTDSJQUJPOGBDUPSTUIBUBSFJOWPMWFEJOWFSUFCSBUFFNCSZPOJDEFWFMPQNFOU  'PSFYBNQMF 
BCOPSNBMJUJFTPG409FYQSFTTJPOBSFBTTPDJBUFEXJUIEFWFMPQNFOUBMBOPNBMJFTJOWPMWJOHUIF$/4 DSBOJPGBDJBMCPOFT BOEQJUVJUBSZ m  
XIJMFBCOPSNBMJUJFTPG43:FYQSFTTJPOBSFBTTPDJBUFEXJUIEJTPSEFSTPGTFYVBMEFWFMPQNFOU  *UJTMJLFMZUIBUUIFEFMFUJPOJOTFSUJPODBVTFTB
EJTSVQUJPOPG409SFHVMBUPSZFMFNFOUTBOEUIFSFCZFYFSUTBQPTJUJPOFGGFDUPO409FYQSFTTJPO

genomic elements such as enhancers, repressors, or insulators
that may be involved in transcription regulation have been
reported to be located up to 1 Mb upstream or downstream of
the transcriptional unit (14). As a first step in exploring such a
possibility, we examined for Sox3 expression by in situ hybridization (Figure 6) in the pharyngeal pouches and developing
parathyroids of mouse embryos, as such human tissues are not
available. We also assessed for Casr expression, which has been
reported to be particularly expressed in parathyroid and thyroid
C cells that produce calcitonin (6), as a control. These studies
revealed Casr expression, as early as 10.5 days post coitum (dpc),
in the parathyroid precursor tissue at the endodermal margin of
the third pharyngeal pouch (Figure 6). At this stage, on serial sections, Sox3 expression was detected in an adjacent but nonoverlapping domain, in the posterior margin of the third, and also
second, pharyngeal pouch. Sox3 expression was also observed at
13.5 and 15.5 dpc, in the developing parathyroids and thymic
and thyroid rudiments, but this was dramatically reduced by
18.5 dpc. In contrast, Casr was strongly and uniformly expressed,
at 18.5 dpc, in the parathyroids, while in the thyroid its expression was clustered in foci that may likely represent C cells (6).
Thus, Sox3 is expressed between 10.5 and 15.5 dpc in the second
and third pharyngeal pouches and the developing parathyroids.
These findings are consistent with the hypothesis that SOX3
misexpression may lead to abnormalities of parathyroid development. Such misexpression of SOX3 could be caused by a position effect resulting from the deletion-insertion [del(X)(q27.1)
The Journal of Clinical Investigation

inv ins (X;2)(q27.1;p25.3)], which is situated 67 kb downstream
of SOX3 and is associated with X-linked recessive HPT.
%JTDVTTJPO
Our studies have identified a novel molecular deletion-insertion involving chromosomes Xq27.1 and 2p25.3 in patients with
X-linked recessive HPT due to parathyroid agenesis (11). Deletioninsertions and translocations are well documented in the etiology
of cancers, e.g., thyroid carcinomas and leukemias (31, 32), and
in nonfamilial forms of diseases such as DiGeorge and HDR syndromes (1, 2, 12). However, to our knowledge, this is the first report
of a stably inherited germline X-autosomal rearrangement that
causes disease. This deletion-insertion is likely to have arisen, in
the founder, by nonhomologous recombination, and the (at) dinucleotide-rich repetitive sequence associated with the centromeric
breakpoint is consistent with this postulated mechanism (33). This
event appears to be an extraordinarily rare one that likely occurred
once and more than a century ago in North America, as only 2
related kindreds with X-linked recessive HPT have been reported,
and both are from Missouri (4, 5, 10). Moreover, our identification
of this deletion-insertion highlights the important role for genetic
abnormalities that involve noncoding regions in causing disease,
a feature that is likely to be of significance in the search for the
molecular basis of other Mendelian inherited diseases for which
coding region abnormalities have not been identified (14).
The manner in which this deletion-insertion [del(X)(q27.1) inv
ins (X;2)(q27.1;p25.3)], which involves a loss of 23–25 kb of non-
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POBTFSJBMTFDUJPOBUEQD0F FTPQIBHVT5S USBDIFB5IFTF
SFTVMUTEFNPOTUSBUFUIBU4PYJTFYQSFTTFE CFUXFFOEQDBOE
EQD JOUIFQIBSZOHFBMQPVDIFTBOEEFWFMPQJOHQBSBUIZSPJETPG
UIFNPVTFFNCSZP4DBMFCBST NN

coding Xq27.1 sequence and an inverted insertion of 305–340 kb
from chromosome 2p25.3 to Xq27.1 in the founder (Figure 5),
affects the embryonic development of the parathyroids from
the third and fourth pharyngeal pouches in humans remains to
be elucidated. At least 4 possible explanations could be considered. First is the possibility that trisomy of the inserted 2p25.3
sequence may result in a dosage effect that alters parathyroid
development. However, this seems unlikely, as patients with 2p
trisomy have not been reported to suffer from hypocalcemia or
HPT (34). Moreover, such 2p25.3 trisomy occurs in the X-linked
recessive HPT carrier females, who are normocalcemic and do
not have HPT (4, 5). Thus, increased dosage of 2p25.3 is not the
cause of X-linked recessive HPT.
Second is the possibility that expression of abnormal splice
variants of SNTG2 may disrupt parathyroid development. SNTG2
belongs to the family of SYNTROPHIN proteins, which contain
at least one pleckstrin homology (PH) domain, a PSD-95, discslarge, Z0-1 (PDZ) domain, and a C-terminal syntrophin unique
(SU) region (35). All of the syntrophin proteins associate with
dystrophin and dystrobrevin through an interaction between
the SU and adjacent PH domain (29, 36), while the PDZ domain
interacts with receptors, ion channels, and other signaling proteins (37–39). Thus, an SNTG2 isoform may regulate parathyroid
development by its action as an adaptor protein that either links
transmembrane receptors to intracellular signaling cascades or
facilitates recycling of G protein–coupled receptors in the process
of receptor resensitization. This possibility, although attractive,
is unlikely, as the SNTG2 transcripts that result from the inser
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tion, which contains approximately 61 kb of intron 1 together
with exons 2–16 (Figure 5), do not have open reading frames and
hence lack the critical PDZ, SU, and PH domains.
Third is the possibility that the 23–25 kb deleted Xq27.1
sequence contains an unidentified gene whose loss disrupts parathyroid development. However, this is unlikely, as the 23–25 kb
DNA sequence is not reported to contain genes or ESTs, and our
studies using EBV-transformed lymphoblastoid RNA failed to
detect any transcripts. Furthermore, a patient who has a deletion
spanning the approximately 1-Mb interval from FACTOR 9 (F9) to
DXS984 (Figure 1) has been reported to suffer from hemophilia B
and mental retardation but not hypocalcemia or HPT (13). Thus,
it seems likely that this 23–25 kb deleted region is noncoding.
Fourth is the possibility that this noncoding region could contain regulatory regions for SOX3, which is located 67 kb telomeric to the deletion-insertion. Thus, a disruption of such putative
regulatory sequences that may alter SOX3 expression would be
postulated to lead to parathyroid agenesis and X-linked recessive
HPT. Our demonstration that Sox3 is expressed in the third pharyngeal pouch and developing parathyroids of mouse embryos
between 10.5 and 15.5 dpc (Figure 6) provides support for such
a role of SOX3 in parathyroid genesis. SOX3 has not previously
been shown to be expressed in the parathyroids, and thus our
results add to the growing list of transcription factors, which
include GCMB, GATA3, TBX1, HOXA3, PAX1, and PAX9, that
operate in parathyroid development (1, 12, 24, 40). Sox3 is also
expressed in the infundibulum of the developing pituitary and
presumptive hypothalamus of mouse embryos, with its expression in the latter being maintained in the adult (15, 41). Moreover, SOX3 abnormalities are associated with X-linked hypopituitarism and with X-linked mental retardation that occurs with
growth hormone deficiency (15, 17, 18).
SOX3 belongs to a family of genes encoding high-mobility group
box transcription factors and is related to SRY, the sex-determining gene on the Y chromosome. The mouse homolog is expressed
in the prestreak embryo and subsequently in the developing
CNS that includes the region of the ventral diencephalon, which
induces development of the anterior pituitary and gives rise to
the hypothalamus (15, 41, 42); olfactory placodes; and parathy-
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roids (Figure 6). Patients with X-linked hypopituitarism have
been reported to have duplications involving a 686-kb to 13-Mb
region that contains SOX3 (15–17), and overexpression of SOX3
has been reported to inhibit Wnt signaling, which has an important role in pituitary development (43). Furthermore, increased
levels of SOX3 have been shown to cause developmental hypoplasia of tissues, such as the lens and otic placodes in fish embryos
(44). Reduced levels of SOX3 expression also result in hypopituitarism. Thus, SOX3-null mice have abnormal pituitary development
associated with hypopituitarism, craniofacial abnormalities, and
midline CNS defects (41). These phenotypic features are similar
to those observed in patients with X-linked hypopituitarism and
with X-linked mental retardation and growth hormone deficiency
who have in-frame duplications of 21 bp or 33 bp encoding for
7 or 11 alanines, respectively, in a polyalanine tract of the SOX3
gene (17, 18). The polyalanine tract expansion resulted in a reduction in SOX3 transcriptional activity that was associated with an
impaired nuclear localization of the mutant protein (17). These
findings demonstrate that pituitary development is sensitive to
SOX3 dosage, and that both loss- and gain-of-function mutations
can result in X-linked hypopituitarism (15, 16, 18, 41, 45).
Patients with X-linked hypopituitarism have not been reported
to suffer from HPT (15–18), and, conversely, the patients affected
with X-linked recessive HPT do not suffer from hypopituitarism
(4, 5, 8). These clinical differences may be due to the differences
in the temporal expression patterns of SOX3 in the pituitary
and parathyroids or to interactions with different tissue-specific enhancers or repressors. Alternatively, they may be due to
differences in the locations of the associated SOX3 genomic
abnormalities, and it is important to note that X-linked hypopituitarism is associated with either duplications of the entire
SOX3 coding region or with an intragenic expansion of a polyalanine tract (15–18), whereas X-linked recessive HPT is associated with a deletion that is approximately 67 kb downstream
from the SOX3 coding region (Figure 5). This situation may be
analogous to that reported to occur in disorders associated with
abnormalities of the gene encoding sonic hedgehog (SHH) (14).
SHH is a secreted protein that provides key inductive signals
for the patterning of ventral neural tube, the anterior posterior
limb axis, and the ventral somites (14). SHH gene abnormalities lead to holoprosencephaly type 3 (HPE3) and preaxial polydactyly (PPD) in humans (14). HPE3 is caused by deletions or
point mutations that involve the coding region and result in
haploinsufficiency of SHH, while PPD is caused by breakpoints
or point mutations within a limb regulatory element that is 1
Mb upstream of SHH (14). These findings illustrate that phenotypes caused by mutations in regulatory elements can be very
different from those caused by mutations of coding regions
and that point mutations in regulatory elements at a distance
as far as 1 Mb from the gene promoter can have a detrimental affect on embryonic development (14). Thus, it seems likely
that the differences between X-linked recessive HPT and hypopituitarism occur because the HPT deletion-insertion, which is
approximately 67 kb downstream of SOX3, involves disruption
of regulatory elements, whereas the abnormalities resulting in
hypopituitarism involve alterations of the SOX3 coding region.
It is also important to note that the disruption in the regulatory
region could also lead to upregulation or misregulation of the
gene, thereby resulting in phenotypes due to gain-of-function
(i.e., hypermorphic or neomorphic).
The Journal of Clinical Investigation

The location of the deletion-insertion approximately 67 kb
downstream of SOX3 in X-linked recessive HPT patients is likely
to result in altered SOX3 expression, as SOX3 expression has been
reported to be sensitive to position effects caused by X chromosome abnormalities (14, 19). Indeed, reporter-construct studies
of the mouse Sox3 gene have demonstrated the presence of both
5′ and 3′ regulatory elements (46), and thus it is possible that
the deletion-insertion in the X-linked recessive HPT patients
may have a position effect on SOX3 expression and parathyroid
development from the pharyngeal pouches. Indeed such position effects on SOX genes, which may be exerted over large distances, have been reported. For example, the very closely related
Sox2 gene has been shown to have regulatory regions spread
over a long distance, both 5′ and 3′ to the coding region (47),
and disruption of sequences at some distance 3′ (>20 kb) have
recently been reported to lead to loss of expression in the developing inner ear and absence of sensory cells, whereas expression
in other sites is unaffected (48). Similarly for the SRY gene, which
probably originated from SOX3 (13), both 5′ and 3′ deletions
result in abnormalities of sexual development (14, 19, 49), and
translocation breakpoints more than 1 Mb upstream of the SOX9
gene have been reported to result in Campomelic dysplasia due
to removal of elements that regulate SOX9 expression (14, 19).
Thus, our studies, which have identified a molecular deletioninsertion that may cause a position effect on SOX3 expression
leading to X-linked recessive HPT, point to a potential role for
the SOX3 gene in the embryological development of the parathyroid glands from the pharyngeal pouches.
.FUIPET
Families. Two related kindreds from Missouri, USA, in whom idiopathic
HPT had been inherited in an X-linked recessive manner in 5 or more generations (4, 5) and in whom linkage between the disease and polymorphic
loci from chromosome Xq26–27 (Figure 1) had been established (7–9), were
investigated. Venous blood was collected, with approved Human Studies
Committee (Washington University School of Medicine) guidelines used
to obtain informed consent, from 61 family members (6 affected males, 11
carrier females and 44 unaffected [16 males, 28 females]) and 9 unrelated
males with idiopathic HPT, as previously reported (7, 8).
Analysis of DNA and RNA. DNA was prepared from peripheral blood
leukocytes or from EBV-transformed lymphoblastoids, and RNA
was prepared from EBV-transformed lymphoblastoids, as previously
described (3). Oligonucleotide primers were designed for use in PCR
amplification of DNA sequences, as previously reported (3, 9, 20) to:
detect SNPs; characterize the boundaries of deletions (ISP3 5′-GGGCTAACGAGAACGCAGAGGC-3′; XSPF 5′-GCTAGTAATGTTCTCTGTCTTGAATTTGCCC-3′; XSPR 5′-GGATCCTCATATCCCACTGTGGTCAAAGG-3′) and insertions by use of STSs (STS a forward
(F) 5′-AGGTGGCAATTTCAAGAGTGC-3′, reverse (R) 5′-CCGTGTGAAGCCTATGACTGC-3′; STS b F 5′-GCAACTAAAGAAGGGCTTAGAGG-3′, R 5′-CACAATACTTCTGGAGGCAAGG-3′; STS c F 5′-CCTAACTTTGCCCCTTCACTGC-3′, R 5′-TGGAGGAAGAAAACTTTGAGC-3′;
STS d F 5′-TGCCTCAGTCTCCTCACTTGGC-3′, R 5′-CTCATATCCTGCCACCAAATTCC-3′; STS e F 5′-TGGCTCACACCTGTAAATACC-3′, R 5′GCAACATCGGTGGGAACAGCAG-3′); generate probes for screening of
YAC, PAC, and Fosmid libraries; determine the chromosomal locations
of novel genomic sequences by use of a rodent-human monochromosomal somatic cell hybrid panel (ISP1 5′-CCCATTTAAGTATAAAACTTATGTTCCTCC-3′; ISP2 5′-CGTGAATCCCTGCATTCCCGTGAGG-3′);
and identify cDNAs using 5′ RACE (30). Oligonucleotide primers were
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also used with RNA in RT-PCR that utilized avian myeloblastosis virus
reverse transcriptase (Life Sciences Inc.) to identify transcripts, as previously described (3, 9). The DNA sequences of PCR products were determined using Taq polymerase cycle sequencing and a semi-automated
laser detection system (Sequencer 373A; Applied Biosystems), as previously reported (9). High-molecular-weight DNA was used for restriction
mapping using 4-fold excess of the “rare cutter” endonuclease SfiI and
the resulting fragments separated by PFGE; transferred by the method of
Southern to Hybond-N+ (Amersham Biosciences UK Ltd.) membranes,
which were hybridized using a [32P]-labeled DNA probe for SOX3 (F 5′TCCGAGCAGGTATATAAGGGG-3′; R 5′-TTCGCACTACTCTTGCCTGC-3′); and visualized by autoradiography (20).
Isolation, preparation, and analysis of YAC, BAC, PAC, and Fosmid clones.
BAC clones were identified using BLAST and the NCBI GenBank database. YAC clones were identified from the CEPH megaYAC library (27),
and PAC and Fosmid clones were identified from the human chromosome 2–specific filter libraries LL02NP04 and LL02NC03 (26), respectively, using [32P]-labeled DNA probes. These DNA probes were generated
from PCR products using the Megaprime DNA labeling system, according to the manufacturer’s recommendations (Amersham Biosciences UK
Ltd.). The DNA sequences of the YAC, PAC, and Fosmid clones were not
available, and the terminal portions of these clones were isolated using
ligation-mediated end rescue methods such as inverse or vectorette PCR
(20, 22, 50) and the DNA sequences of the products determined. A contig
consisting of these clones was assembled, as described previously (20).
These clones were prepared and labeled by incorporation of labeled dUTP
for use on metaphase spreads and FISH.
Metaphase- and DNA fiber–FISH. Metaphase chromosome spreads were
prepared from EBV-transformed lymphoblastoid cells (3) following
standard procedures, and single- and dual-color FISH was performed, as
previously described (28), using biotin- and digoxigenin-labeled probes.
Biotinylated probes were detected with Texas red–conjugated streptavidin
(Invitrogen Corp.), and digoxigenin labeled probes were detected with a
mouse anti-digoxigenin antibody (Roche Diagnostics Corp.) and goat
anti-mouse Alexa-488 (Invitrogen Corp.). The slides were mounted with
VECTASHIELD (Vector Laboratories) containing DAPI for chromosome
counterstaining. A minimum of 25 metaphases were analyzed for each
hybridization experiment using an Olympus BX-51 epifluorescence microscope coupled to a SenSys charge-coupled device camera (Photometrics;
Roper Scientific Inc.). Texas red, Alexa-488, and DAPI fluorescence images
were taken as separate gray-scale images using specific filter combinations
and then pseudocolored and merged using the software package Genus
version 2.81 (Applied Imaging International). DNA fiber slides were prepared as described previously (28) and triple-color FISH performed using
biotin-, digoxigenin-, and Alexa-594–labeled probes. Biotinylated probes
were visualized using fluorescein-conjugated streptavidin, and digoxigenin-labeled probes were visualized using mouse anti-digoxigenin (Roche
Diagnostics Corp.) followed by a layer of rabbit anti-mouse Cy5 (Stratech
Scientific Ltd.) and a final layer of goat anti-rabbit Cy5 (Stratech Scientific Ltd.). Probes labeled with Alexa-594 dUTP (Invitrogen Corp.) were
visualized directly. The slides were mounted with VECTASHIELD (Vector
Laboratories), and images were captured and analyzed using a Bio-Rad
MRC1024 confocal microscope (Bio-Rad Laboratories).
Genomic library construction. Leukocyte DNA from a male affected with
X-linked recessive HPT (individual IV.15 from family W/81; Figure 2)
and an unaffected (control) male (individual IV.14 from family W/81;
Figure 2) was digested with BamHI, EcoRI, HindIII, HpaII, and RsaI and
used to construct genomic libraries utilizing the Vectorette II system
(Sigma-Aldrich) (22). In order to enrich the source of the HPT insert
abnormality, flow-sorted X chromosomes extracted from EBV-trans
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formed lymphoblastoids (51) of a male affected with X-linked recessive HPT (individual IV.15 from family W/81; Figure 2) were utilized
to generate EcoRI, RsaI, and TaqI vectorette libraries, using previously
reported methods (22, 51). These libraries were employed as template
DNA for PCR amplification using XSPs in conjunction with a Vectorette unit binding primer (Sigma-Aldrich). Targeted PCR products were
identified using an oligomer-extension “hot blot” assay, as previously
described (23). Targeted products were then excised from a duplicate gel,
the DNA extracted, and their sequence determined using Taq polymerase
cycle sequencing (9, 12, 24).
Detection of Sox3 and Casr expression in mouse embryos by in situ hybridization. Parkes mice were staged according to the date of the vaginal plug.
Embryos were harvested, fixed overnight in 4% paraformaldehyde at 4°C,
cryoprotected in 20% sucrose, and embedded in OCT (BDH), using previously described methods (41). In situ hybridizations using cryosections
were performed as described previously (52) using Sox3 (41) and Casr riboprobes. The Casr riboprobe, which was 979 bp in size, was generated by
RT-PCR using total RNA from mouse (129/Ola) embryonic stem cells
together with primers specific to exon 2 (5′-AGACCAGAGTCTGTGGAGTGC-3′, nucleotides 685–705; NM_013803 Mus musculus Calciumsensing receptor [Casr], mRNA) and exon 4 (5′-CCTTCCTCGTGACTTCTCACG-3′, nucleotides 1,663–1,643). The RT-PCR product was subcloned
into pGEM-T, the construct linearized using NdeI, and an antisense
digoxigenin-labeled Casr probe generated using T7 RNA polymerase. All
experiments on mice were performed using protocols approved under the
United Kingdom Animal (Scientific Procedures) Act. All animal procedures were authorized by the United Kingdom Home Office.
Database searches. Nucleotide sequence analyses and comparisons were
performed using the GenBank/BLAST (http://www.ncbi.nlm.nih.gov/
BLAST/), Ensembl/BLAST (http://www.ensembl.org), and NIX (no longer available) databases and programs available in 2001–2004. OMIM was
accessed on the World Wide Web (http://www.ncbi.nlm.nih.gov/omim/).
Linkage analysis. Data from the present and previously reported studies (7, 8) of the 2 related kindreds, families P/60 (4) and W/81 (5), were
pooled for linkage studies. Conventional 2-point LOD scores were calculated using a web-based linkage computer application, GLUE (LITBIO;
http://www.litbio.org).

"DLOPXMFEHNFOUT
This work was supported by grants from the MRC (United
Kingdom) (to M.R. Bowl, M.A. Nesbit, B. Harding, K. Rizzoti,
R. Lovell-Badge, and R.V. Thakker), the Wellcome Trust (United
Kingdom) (to E. Levy, A. Jefferson, E. Volpi, and R.V. Thakker),
and the Shriners Hospitals for Children (USA) (to M.P. Whyte).
M.R. Bowl was an MRC PhD Student. We thank K. Boone
(Weatherall Institute of Molecular Medicine) for help with flowsorting of X chromosomes.
Received for publication December 12, 2004, and accepted in
revised form July 12, 2005.
Address correspondence to: Rajesh V. Thakker, Academic Endocrine Unit, Nuffield Department of Medicine, University of
Oxford, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), Churchill Hospital, Headington, Oxford OX3
7LJ, United Kingdom. Phone: 44-1865-857501; Fax: 44-1865857502; E-mail: rajesh.thakker@ndm.ox.ac.uk.
Michael R. Bowl and M. Andrew Nesbit contributed equally to this
work.

http://www.jci.org

Volume 115

Number 10

October 2005

Downloaded on July 12, 2013. The Journal of Clinical Investigation. More information at www.jci.org/articles/view/24156

SFTFBSDIBSUJDMF
1. Thakker, R.V. 2004. Genetics of endocrine and
metabolic disorders: parathyroid. Rev. Endocr.
Metab. Disord. 5:37–51.
2. Baldini, A. 2003. DiGeorge’s syndrome: a gene at
last. Lancet. 362:1342–1343.
3. Parkinson, D.B., and Thakker, R.V. 1992. A donor
splice site mutation in the parathyroid hormone
gene is associated with autosomal recessive hypoparathyroidism. Nat. Genet. 1:149–152.
4. Peden, V.H. 1960. True idiopathic hypoparathyroidism as a sex-linked recessive trait. Am. J. Hum.
Genet. 12:323–337.
5. Whyte, M.P., and Weldon, V.V. 1981. Idiopathic
hypoparathyroidism presenting with seizures
during infancy: X-linked recessive inheritance in a
large Missouri kindred. J. Pediatr. 99:608–611.
6. Brown, E.M., and MacLeod, R.J. 2001. Extracellular
calcium sensing and extracellular calcium signaling. Physiol. Rev. 81:239–297.
7. Thakker, R.V., Davies, K.E., Whyte, M.P., Wooding,
C., and O’Riordan, J.L. 1990. Mapping the gene
causing X-linked recessive idiopathic hypoparathyroidism to Xq26-Xq27 by linkage studies. J. Clin.
Invest. 86:40–45.
8. Trump, D., et al. 1998. Localisation of X linked
recessive idiopathic hypoparathyroidism to a 1.5
Mb region on Xq26-q27. J. Med. Genet. 35:905–909.
9. Nesbit, M.A., et al. 2004. X-linked hypoparathyroidism region on Xq27 is evolutionarily conserved
with regions on 3q26 and 13q34 and contains a
novel P-type ATPase. Genomics. 84:1060–1070.
10. Mumm, S., Whyte, M.P., Thakker, R.V., Buetow, K.H.,
and Schlessinger, D. 1997. mtDNA analysis shows
common ancestry in two kindreds with X-linked recessive hypoparathyroidism and reveals a heteroplasmic
silent mutation. Am. J. Hum. Genet. 60:153–159.
11. Whyte, M.P., Kim, G.S., and Kosanovich, M. 1986.
Absence of parathyroid tissue in sex-linked recessive
hypoparathyroidism [letter]. J. Pediatr. 109:915.
12. Van Esch, H., et al. 2000. GATA3 haplo-insufficiency causes human HDR syndrome. Nature.
406:419–422.
13. Stevanovic, M., Lovell-Badge, R., Collignon, J., and
Goodfellow, P.N. 1993. SOX3 is an X-linked gene
related to SRY. Hum. Mol. Genet. 2:2013–2018.
14. Kleinjan, D.A., and van Heyningen, V. 2005. Longrange control of gene expression: emerging mechanisms and disruption in disease. Am. J. Hum. Genet.
76:8–32.
15. Solomon, N.M., et al. 2004. Array comparative
genomic hybridisation analysis of boys with X
linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3.
J. Med. Genet. 41:669–678.
16. Solomon, N.M., et al. 2002. Increased gene dosage
at Xq26-q27 is associated with X-linked hypopituitarism. Genomics. 79:553–559.
17. Woods, K.S., et al. 2005. Over- and underdosage of
SOX3 is associated with infundibular hypoplasia and
hypopituitarism. Am. J. Hum. Genet. 76:833–849.
18. Laumonnier, F., et al. 2002. Transcription factor
SOX3 is involved in X-linked mental retardation
with growth hormone deficiency. Am. J. Hum.

Genet. 71:1450–1455.
19. Kleinjan, D.J., and van Heyningen, V. 1998. Position effect in human genetic disease. Hum. Mol.
Genet. 7:1611–1618.
20. Trump, D., et al. 1996. Construction of a YAC contig and an STS map spanning 3.6 megabase pairs
in Xp22.1. Hum. Genet. 97:60–68.
21. Hui, E.K., Wang, P.C., and Lo, S.J. 1998. Strategies for cloning unknown cellular flanking DNA
sequences from foreign integrants. Cell. Mol. Life Sci.
54:1403–1411.
22. Proffitt, J., Fenton, J., Pratt, G., Yates, Z., and Morgan, G. 1999. Isolation and characterisation of
recombination events involving immunoglobulin
heavy chain switch regions in multiple myeloma
using long distance vectorette PCR (LDV-PCR).
Leukemia. 13:1100–1107.
23. Parker, J.D., and Burmer, G.C. 1991. The oligomer
extension “hot blot”: a rapid alternative to Southern blots for analyzing polymerase chain reaction
products. Biotechniques. 10:94–101.
24. Nesbit, M.A., et al. 2004. Characterization of
GATA3 mutations in the hypoparathyroidism,
deafness, and renal dysplasia (HDR) syndrome.
J. Biol. Chem. 279:22624–22634.
25. Kelsell, D.P., et al. 1995. Development of a panel of
monochromosomal somatic cell hybrids for rapid
gene mapping. Ann. Hum. Genet. 59:233–241.
26. Gingrich, J.C., et al. 1996. Construction and characterization of human chromosome 2-specific cosmid,
fosmid, and PAC clone libraries. Genomics. 32:65–74.
27. Chumakov, I., et al. 1992. Continuum of overlapping clones spanning the entire human chromosome 21q. Nature. 359:380–387.
28. Bochukova, E.G., Jefferson, A., Francis, M.J., and
Monaco, A.P. 2003. Genomic studies of gene
expression: regulation of the Wilson disease gene.
Genomics. 81:531–542.
29. Piluso, G., et al. 2000. Gamma1- and gamma2-syntrophins, two novel dystrophin-binding proteins localized in neuronal cells. J. Biol. Chem. 275:15851–15860.
30. Frohman, M.A., Dush, M.K., and Martin, G.R.
1988. Rapid production of full-length cDNAs from
rare transcripts: amplification using a single genespecific oligonucleotide primer. Proc. Natl. Acad. Sci.
U. S. A. 85:8998–9002.
31. Grieco, M., et al. 1990. PTC is a novel rearranged
form of the ret proto-oncogene and is frequently
detected in vivo in human thyroid papillary carcinomas. Cell. 60:557–563.
32. Faderl, S., et al. 1999. The biology of chronic
myeloid leukemia. N. Engl. J. Med. 341:164–172.
33. Edelmann, L., et al. 2001. AT-rich palindromes
mediate the constitutional t(11;22) translocation.
Am. J. Hum. Genet. 68:1–13.
34. Aviram-Goldring, A., et al. 2000. Molecular cytogenetic studies in three patients with partial trisomy
2p, including CGH from paraffin-embedded tissue. Am. J. Med. Genet. 91:74–82.
35. Albrecht, D.E., and Froehner, S.C. 2002. Syntrophins and dystrobrevins: defining the dystrophin
scaffold at synapses. Neurosignals. 11:123–129.
36. Kachinsky, A.M., Froehner, S.C., and Milgram, S.L.

The Journal of Clinical Investigation

http://www.jci.org

Volume 115

1999. A PDZ-containing scaffold related to the
dystrophin complex at the basolateral membrane
of epithelial cells. J. Cell Biol. 145:391–402.
37. Hogan, A., et al. 2001. Interaction of gamma 1-syntrophin with diacylglycerol kinase-zeta. Regulation
of nuclear localization by PDZ interactions. J. Biol.
Chem. 276:26526–26533.
38. Oak, S.A., Russo, K., Petrucci, T.C., and Jarrett,
H.W. 2001. Mouse alpha1-syntrophin binding to
Grb2: further evidence of a role for syntrophin in
cell signaling. Biochemistry. 40:11270–11278.
39. Kornau, H.C., Schenker, L.T., Kennedy, M.B., and
Seeburg, P.H. 1995. Domain interaction between
NMDA receptor subunits and the postsynaptic
density protein PSD-95. Science. 269:1737–1740.
40. Scambler, P.J. 2000. The 22q11 deletion syndromes.
Hum. Mol. Genet. 9:2421–2426.
41. Rizzoti, K., et al. 2004. SOX3 is required during the
formation of the hypothalamo-pituitary axis. Nat.
Genet. 36:247–255.
42. Collignon, J., et al. 1996. A comparison of the properties of Sox-3 with Sry and two related genes, Sox-1
and Sox-2. Development. 122:509–520.
43. Zorn, A.M., et al. 1999. Regulation of Wnt signaling
by Sox proteins: XSox17 alpha/beta and XSox3 physically interact with beta-catenin. Mol. Cell. 4:487–498.
44. Koster, R.W., Kuhnlein, R.P., and Wittbrodt, J.
2000. Ectopic Sox3 activity elicits sensory placode
formation. Mech. Dev. 95:175–187.
45. Schlosser, G., and Ahrens, K. 2004. Molecular anatomy of placode development in Xenopus laevis.
Dev. Biol. 271:439–466.
46. Brunelli, S., Silva Casey, E., Bell, D., Harland, R., and
Lovell-Badge, R. 2003. Expression of Sox3 throughout the developing central nervous system is
dependent on the combined action of discrete, evolutionarily conserved regulatory elements. Genesis.
36:12–24.
47. Uchikawa, M., Ishida, Y., Takemoto, T., Kamachi,
Y., and Kondoh, H. 2003. Functional analysis of
chicken Sox2 enhancers highlights an array of
diverse regulatory elements that are conserved in
mammals. Dev. Cell. 4:509–519.
48. Kiernan, A.E., et al. 2005. Sox2 is required for sensory organ development in the mammalian inner
ear. Nature. 434:1031–1035.
49. Berta, P., et al. 1990. Genetic evidence equating
SRY and the testis-determining factor. Nature.
348:448–450.
50. Hui, E.K., Wang, P.C., and Lo, S.J. 1998. Strategies for cloning unknown cellular flanking DNA
sequences from foreign integrants. Cell. Mol. Life Sci.
54:1403–1411.
51. Carter, N.P., et al. 1990. Study of X chromosome
abnormality in XX males using bivariate flow
karyotype analysis and flow sorted dot blots.
Cytometry. 11:202–207.
52. Schaeren-Wiemers, N., and Gerfin-Moser, A.
1993. A single protocol to detect transcripts of
various types and expression levels in neural tissue and cultured cells: in situ hybridization using
digoxigenin-labelled cRNA probes. Histochemistry.
100:431–440.

Number 10

October 2005



